Skip to main content
Premium Trial:

Request an Annual Quote

Affy Sequencing Patent Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, July 3 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, June 30.



1.   New Affymetrix Patent Could Cause Trouble for Next-Gen Sequencing Players (from June 29)

2. Invitrogen, Affy, Sigma-Aldrich Among Vendors to Occupy New Nasdaq Tier (from June 28)

3. Next-Gen Sequencers, Led by 454's GS20, Gain Ground in Small-RNA Analysis (from June 26)

4. Epigenomics and Sanger Institute Release First Results from Human Epigenome Project (from June 26)

5. Fisher Subsidiary Abgene Licenses ABI Tech to Offer PCR-related Products, Develop Its Own (from June 29)

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.